Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (321-330 of 1,623) with videos related to

Pageof 163
Sort By:
Journal of Women'S Health (2002)|February 28, 2007
Cancer screening: understanding barriers to optimal use of evidence-based strategiesMaurie Markman
The Oncologist|February 14, 2007
New, expanded, and modified use of approved antineoplastic agents in ovarian cancerMaurie Markman
Trends in Pharmacological Sciences|September 2, 2008
Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategiesMaurie Markman
Critical Reviews in Oncology/Hematology|January 1, 1985
Intracavitary chemotherapyM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Serious ethical dilemma of single-agent pegylated liposomal Doxorubicin employed as a control arm in ovarian cancer chemotherapy trialsMaurie Markman
The International Journal of Psycho-Analysis|June 12, 2010
The past as resistance, the past as constructedHenry Markman
Seminars in Oncology|May 24, 2006
Unresolved issues in the chemotherapeutic management of gynecologic malignanciesMaurie Markman
Expert Opinion on Pharmacotherapy|August 13, 2009
Antiangiogenic drugs in ovarian cancerMaurie Markman
Gynecologic Oncology|September 22, 2009
"Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma" Safra T, et al (Gynecol Oncol 2009; 114:215-218)Maurie Markman
Current Oncology Reports|May 12, 2011
Information overload in oncology practice and its potential negative impact on the delivery of optimal patient careMaurie Markman
Pageof 163

Showing results (321-330 of 1,623) with videos related to

Sort By:
Pageof 163
Journal of Women'S Health (2002)|February 28, 2007
Cancer screening: understanding barriers to optimal use of evidence-based strategiesMaurie Markman
The Oncologist|February 14, 2007
New, expanded, and modified use of approved antineoplastic agents in ovarian cancerMaurie Markman
Trends in Pharmacological Sciences|September 2, 2008
Antineoplastic agents in the management of ovarian cancer: current status and emerging therapeutic strategiesMaurie Markman
Critical Reviews in Oncology/Hematology|January 1, 1985
Intracavitary chemotherapyM Markman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2010
Serious ethical dilemma of single-agent pegylated liposomal Doxorubicin employed as a control arm in ovarian cancer chemotherapy trialsMaurie Markman
The International Journal of Psycho-Analysis|June 12, 2010
The past as resistance, the past as constructedHenry Markman
Seminars in Oncology|May 24, 2006
Unresolved issues in the chemotherapeutic management of gynecologic malignanciesMaurie Markman
Expert Opinion on Pharmacotherapy|August 13, 2009
Antiangiogenic drugs in ovarian cancerMaurie Markman
Gynecologic Oncology|September 22, 2009
"Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma" Safra T, et al (Gynecol Oncol 2009; 114:215-218)Maurie Markman
Current Oncology Reports|May 12, 2011
Information overload in oncology practice and its potential negative impact on the delivery of optimal patient careMaurie Markman
Pageof 163